NMDA receptor gene variations as modifiers in Huntington disease: a replication study

Carsten Saft, Jörg T Epplen, Stefan Wieczorek, G Bernhard Landwehrmeyer, Raymund A C Roos, Justo Garcia de Yebenes, Matthias Dose, Sarah J Tabrizi, David Craufurd, REGISTRY Investigators of the European Huntington's Disease Network, Larissa Arning

Abstract

Several candidate modifier genes which, in addition to the pathogenic CAG repeat expansion, influence the age at onset (AO) in Huntington disease (HD) have already been described. The aim of this study was to replicate association of variations in the N-methyl D-aspartate receptor subtype genes GRIN2A and GRIN2B in the "REGISTRY" cohort from the European Huntington Disease Network (EHDN). The analyses did replicate the association reported between the GRIN2A rs2650427 variation and AO in the entire cohort. Yet, when subjects were stratified by AO subtypes, we found nominally significant evidence for an association of the GRIN2A rs1969060 variation and the GRIN2B rs1806201 variation. These findings further implicate the N-methyl D-aspartate receptor subtype genes as loci containing variation associated with AO in HD.

References

    1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72(6):971-83
    1. Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A 2004;101(10):3498-503
    1. Rubinsztein DC, Leggo J, Chiano M, et al. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci USA 1997;94:3872–6
    1. Arning L, Saft C, Wieczorek S, et al. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner. Hum Genet 2007;122(2):175-82
    1. Andresen JM, Gayan J, Cherny SS, et al. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet 2007;44(1):44-50
    1. Weydt P, Soyal SM, Gellera C, et al. The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease.Mol Neurodegener 2009;4:3
    1. Taherzadeh-Fard E, Saft C, Andrich J, et al. PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 2009;4:10
    1. Gusella JF, MacDonald ME. Huntington's disease: the case for genetic modifiers. Genome Med 2009;1(8):80
    1. Arning L, Haghikia A, Taherzadeh-Fard E, et al. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J Mol Med 2010;88(4):431-6
    1. Orth M, Handley OJ, Schwenke C, et al. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr;2

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa